FDA Expands Approved Use of H1N1 Vaccines to Include Infants and Children
FDA Expands Approved Use of H1N1 Vaccines to Include Infants and Children
November 13, 2009
ROCKVILLE, Md., Nov. 12, 2009--The U.S. Food and Drug Administration
has approved the use of the CSL Limited's 2009 H1N1 influenza vaccine
to include children ages 6 months and older. This vaccine was
previously approved only for use in adults, ages 18 years and older.
"Because children are among those most vulnerable to the 2009 H1N1
virus, having a broader range of children's vaccines available is an
important step in responding to the H1N1 outbreak," said Margaret A.
Hamburg, M.D.,
November 13, 2009
ROCKVILLE, Md., Nov. 12, 2009--The U.S. Food and Drug Administration
has approved the use of the CSL Limited's 2009 H1N1 influenza vaccine
to include children ages 6 months and older. This vaccine was
previously approved only for use in adults, ages 18 years and older.
"Because children are among those most vulnerable to the 2009 H1N1
virus, having a broader range of children's vaccines available is an
important step in responding to the H1N1 outbreak," said Margaret A.
Hamburg, M.D.,
Comentarios
Publicar un comentario